TCG Crossover Management LLC 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-29 06:02 am Unchanged | 2021-09-23 | 13G | Viridian Therapeutics, Inc. VRDN | TCG Crossover Management LLC | 1,314,000 8.200% | 0 (Unchanged) | Filing |
| 2021-09-24 1:59 pm Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | TCG Crossover Management LLC | 1,314,000 13.700% | 400,000 (+43.76%) | Filing |
| 2021-09-10 06:03 am Purchase | 2021-09-01 | 13G | Viridian Therapeutics, Inc. VRDN | TCG Crossover Management LLC | 914,000 9.500% | 914,000 (New Position) | Filing |